Cited 0 time in
심한 임상경과를 보이는 허혈성 대장염의 위험인자
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 이항락 | - |
| dc.date.accessioned | 2021-08-04T00:34:21Z | - |
| dc.date.available | 2021-08-04T00:34:21Z | - |
| dc.date.issued | 2007-11-21 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/65778 | - |
| dc.description.abstract | Background: In general, ischemic colitis has a very good prognosis. However, there are a lot of controversies in relation to the prognostic factors. The aim of this study is to evaluate risk factors of severe ischemic colitis. Method: A retrospective study was undertaken of patients with ischemic colitis hospitalized at the Hanyang University Hospital during the interval 2003-2006. Patients were divided into two groups: those with mild course and those with severe course such as needing operation or systemic inflammatory response syndrome or death. Result: A total of 41 cases (M/F = 13/28, mean age=63.8 years) of biopsy proven ischemic colitis were included, of which 31 (75.6%) showed a mild course and 10(24.4%) showed a severe course. Combined medical diseases of patients were hypertension (n=24), diabetes (n=14), end stage renal disease (n=11), cardiovascular disease (n=5) and malignancy (n=5). Male patient (p=0.049), alcoholics (p=0.025), end stage renal disease (p=0.013), LDH (p=0.002), CRP (p=0.014), peritoneal irritation sign (p=0.001), Bun (p=0.006) and Cr (p=0.002) were the significant risk factors of severe ischemic colitis in univariate analysis. In multivariate analysis, end stage renal disease (p=0.026) was the only significant risk factor of severe ischemic colitis. Conclusions: Careful attention must be paid to end stage renal disease patients having ischemic colitis. | - |
| dc.title | 심한 임상경과를 보이는 허혈성 대장염의 위험인자 | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 2007년 추계 소화기연관학회 합동학술대회 | - |
| dc.citation.conferencePlace | 쉐라톤워커힐호텔 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
